Sam McKaylin is a seasoned professional in the life sciences and machine learning sectors, currently serving as a Life Sciences Venture Capital Research Consultant at Albourne since October 2024. Previously, McKaylin held the position of Senior Machine Learning Engineer at Mosaic TX, focusing on the application of machine learning for cancer therapeutic discovery. Prior experience includes a role as a Data Scientist at Transition Bio, Inc., where McKaylin utilized machine learning to predict small molecule drugs for cancer treatment. McKaylin's background also encompasses educational contributions as a Course Developer at Imperial College London and a diverse range of roles within the media and digital content production sectors. Academic qualifications include a Master of Philosophy in Zoology from the University of Cambridge and a Bachelor of Science in Biological Sciences from Imperial College London.